The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Valsartan Mylan 160mg Film-coated Tablets

160 milligram(s) Film-coated tablet

McDermott Laboratories Ltd., T/A Gerard LaboratoriesPA0577/134/003

Main Information

Trade NameValsartan Mylan 160mg Film-coated Tablets
Active SubstancesValsartan
Strength160 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderMcDermott Laboratories Ltd., T/A Gerard Laboratories
Licence NumberPA0577/134/003

Group Information

ATC CodeC09CA Angiotensin II antagonists, plain
C09CA03 valsartan

Status

Authorised/WithdrawnAuthorised
Licence Issued23/09/2011
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0038-082-003
Interchangeable List DocumentPDF of Interchangeable List
« Back